189 related articles for article (PubMed ID: 11162445)
1. Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells.
Ma D; Huang H; Moscow JA
Biochem Biophys Res Commun; 2000 Dec; 279(3):891-7. PubMed ID: 11162445
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells.
Moscow JA; Gong M; He R; Sgagias MK; Dixon KH; Anzick SL; Meltzer PS; Cowan KH
Cancer Res; 1995 Sep; 55(17):3790-4. PubMed ID: 7641195
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
Zhao R; Gao F; Babani S; Goldman ID
Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
[TBL] [Abstract][Full Text] [Related]
4. The antiepileptic drugs phenobarbital and carbamazepine reduce transport of methotrexate in rat choroid plexus by down-regulation of the reduced folate carrier.
Halwachs S; Lakoma C; Schäfer I; Seibel P; Honscha W
Mol Pharmacol; 2011 Oct; 80(4):621-9. PubMed ID: 21737571
[TBL] [Abstract][Full Text] [Related]
5. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.
Moscow JA; Connolly T; Myers TG; Cheng CC; Paull K; Cowan KH
Int J Cancer; 1997 Jul; 72(1):184-90. PubMed ID: 9212241
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 human leukemia cell line.
Gong M; Yess J; Connolly T; Ivy SP; Ohnuma T; Cowan KH; Moscow JA
Blood; 1997 Apr; 89(7):2494-9. PubMed ID: 9116294
[TBL] [Abstract][Full Text] [Related]
7. Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier.
Zhao R; Gao F; Goldman ID
Biochem Pharmacol; 1999 Nov; 58(10):1615-24. PubMed ID: 10535753
[TBL] [Abstract][Full Text] [Related]
8. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
[TBL] [Abstract][Full Text] [Related]
9. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
[TBL] [Abstract][Full Text] [Related]
10. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of reduced folate carrier may result in folate malabsorption across intestinal brush border membrane during experimental alcoholism.
Hamid A; Wani NA; Rana S; Vaiphei K; Mahmood A; Kaur J
FEBS J; 2007 Dec; 274(24):6317-28. PubMed ID: 18005257
[TBL] [Abstract][Full Text] [Related]
12. Differential usage of the transport systems for folic acid and methotrexate in normal human T-lymphocytes and leukemic cells.
Biswal BK; Verma RS
J Biochem; 2009 Nov; 146(5):693-703. PubMed ID: 19692428
[TBL] [Abstract][Full Text] [Related]
13. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate.
Zhao R; Assaraf YG; Goldman ID
J Biol Chem; 1998 Apr; 273(14):7873-9. PubMed ID: 9525881
[TBL] [Abstract][Full Text] [Related]
14. Stereoselectivity of the reduced folate carrier in Caco-2 cells.
Narawa T; Shimizu R; Takano S; Tsuda Y; Ono K; Yamada H; Itoh T
Chirality; 2005 Oct; 17(8):444-9. PubMed ID: 16096989
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
Kühnel JM; Chiao JH; Sirotnak FM
J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
[TBL] [Abstract][Full Text] [Related]
17. Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier.
Zhao R; Chattopadhyay S; Hanscom M; Goldman ID
Clin Cancer Res; 2004 Dec; 10(24):8735-42. PubMed ID: 15623659
[TBL] [Abstract][Full Text] [Related]
18. Variable expression of RFC1 in human leukemia cell lines resistant to antifolates.
Kobayashi H; Takemura Y; Ohnuma T
Cancer Lett; 1998 Feb; 124(2):135-42. PubMed ID: 9500202
[TBL] [Abstract][Full Text] [Related]
19. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
Weigand M; Hartung G; Roboz J; Sieger S; Wolf M; Sinn H; Schrenk HH; Wiessler M; Frei E
Anticancer Drug Des; 2001; 16(4-5):227-37. PubMed ID: 12049481
[TBL] [Abstract][Full Text] [Related]
20. Large diversity in transport-mediated methotrexate resistance in human leukemia cell line CCRF-CEM established in a high concentration of leucovorin.
Asai S; Miyachi H; Kobayashi H; Takemura Y; Ando Y
Cancer Sci; 2003 Feb; 94(2):210-4. PubMed ID: 12708499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
